Addendum to NICE guideline 100, alcohol-use disorders diagnosis and management of physical complications
A decision was made to update the NICE guideline on management of alcohol use disorders (CG100) following an exceptional surveillance review of corticosteroid treatment for alcohol-related diseases. Topic experts felt that recent publication of the NIHR-funded STOPAH trial represented significant ne...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
London
National Institute for Health and Care Excellence (UK)
2017, April 2017
|
| Series: | NICE guideline addendum: methods, evidence, and recommendations
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | A decision was made to update the NICE guideline on management of alcohol use disorders (CG100) following an exceptional surveillance review of corticosteroid treatment for alcohol-related diseases. Topic experts felt that recent publication of the NIHR-funded STOPAH trial represented significant new evidence that could have an impact on current guideline recommendations |
|---|---|
| Physical Description: | 1 PDF file (128 pages) illustrations |